Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Neurology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Idiopathic intracranial hypertension

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Papilloedema with rapidly worsening acuity or visual fields, severe hypertension, altered consciousness, focal deficit or an acute atypical headache requires urgent same-day hospital, ophthalmology and neurology assessment. Fulminant visual decline may need emergency cerebrospinal-fluid diversion or optic-nerve-sheath surgery; repeated outpatient lumbar puncture is not an adequate vision-saving plan.

Overview

Confirm raised intracranial pressure safely after excluding secondary causes, protect vision through structured ophthalmic monitoring, and use weight, medicine or surgery according to visual risk.

IIH most often affects women of childbearing age with obesity, but demographics never establish or exclude the diagnosis. Headache may mimic chronic migraine and often coexists with medication overuse. Ask about transient greying of vision with posture, pulsatile tinnitus, horizontal diplopia, sustained visual loss and radicular pain. Examine blood pressure urgently to exclude malignant hypertension, visual acuity, colour vision, pupils and ocular movements, and confirm whether optic-disc swelling is genuine papilloedema rather than pseudopapilloedema. A sixth-nerve palsy can occur, but other focal neurological findings are atypical. Visual function, not headache severity, determines immediate threat because substantial field loss can occur without proportionate pain.

Diagnosis requires a sequence. Neuroimaging must show no mass, hydrocephalus, structural or meningeal cause, and venography must exclude cerebral venous sinus thrombosis. Imaging signs such as an empty sella, posterior globe flattening, enlarged optic-nerve sheaths or transverse-sinus narrowing support pressure but are not diagnostic alone. When imaging and procedural safety are satisfactory, lumbar puncture should be performed in lateral decubitus with legs relaxed, allowing the column to settle; record opening pressure and send at least protein, glucose and cell count. An opening pressure above 25 cm CSF in adults is used by consensus, but technique, obesity, anxiety and biological variability mean the number should not be interpreted in isolation. If the pressure conflicts with a compelling phenotype, specialist reassessment or repeat measurement may be safer than dismissing or overdiagnosing disease.

Aetiology

01

Obesity-associated susceptibility

IIH occurs disproportionately in people with obesity, particularly women of reproductive age, although body habitus is a risk association rather than a sufficient diagnosis.

02

Uncertain initiating mechanism

The initiating mechanism remains unknown after secondary disorders are excluded; recognised associations do not establish one causal abnormality in an individual.

Pathophysiology

  1. 1
    Raised intracranial pressure

    Intracranial pressure is elevated despite normal cerebrospinal-fluid composition and no mass, hydrocephalus, venous thrombosis or other identified secondary cause.

  2. 2
    Papilloedema and visual injury

    Raised pressure produces papilloedema, transient visual obscurations and visual-field loss; sustained optic-nerve injury can cause irreversible loss of sight.

  3. 3
    Pain and cranial-nerve effects

    Raised pressure distends pain-sensitive structures and can stretch sixth nerves, producing headache, pulsatile tinnitus, transient visual obscurations and binocular diplopia.

Clinical features and red flags

Papilloedema syndromeRed flag

Bilateral optic-disc swelling with transient visual obscurations, headache or pulsatile tinnitus raises intracranial-pressure concern and needs urgent competent visual assessment.

Sixth-nerve palsyRed flag

Horizontal diplopia from an abduction deficit can occur as a false localising sign; other cranial or limb deficits should prompt a search for an alternative lesion.

Fulminant IIHRed flag

Rapid visual-acuity or field decline over days to weeks represents sight-threatening disease and requires immediate surgical-level escalation rather than routine medication titration.

Pressure-type visual symptomsRed flag

Brief binocular dimming with postural change, enlarging blind spot or progressive peripheral field loss can signal optic-nerve compromise even when central acuity remains good.

Secondary pressure clueRed flag

Pregnancy or puerperium, thrombosis risk, anaemia, tetracycline or vitamin-A exposure, steroid withdrawal, endocrine disease or systemic symptoms demands an active search for secondary intracranial hypertension.

Pseudopapilloedema possibility

Optic-disc drusen and anomalous discs can mimic swelling; specialist imaging and visual testing prevent invasive investigation from resting on an uncertain disc examination.

Investigations

  1. 01
    Formal ophthalmic assessmentFirst step
    Why
    Confirm papilloedema and establish visual acuity, pupils, colour, perimetry, fundus grade and optic-nerve imaging baseline.
    Interpretation and limitations
    Serial visual fields and disc appearance determine urgency; preserved central acuity does not exclude important peripheral field loss.
  2. 02
    MRI brain with MR venography or CT with CT venography
    Why
    Exclude mass, hydrocephalus, meningeal disease and cerebral venous sinus thrombosis before diagnosing idiopathic disease.
    Interpretation and limitations
    Pressure-associated imaging signs are supportive only; a venous filling defect changes the diagnosis and treatment to secondary intracranial hypertension.
  3. 03
    Lumbar puncture opening pressure and CSF
    Why
    Confirm raised pressure and normal fluid composition after imaging shows the procedure is appropriate.
    Interpretation and limitations
    Measure relaxed lateral-decubitus pressure; above 25 cm CSF supports adult diagnosis, but resolve technical or clinical discordance with specialist judgement.
  4. 04
    Blood pressure, FBC and targeted secondary-cause tests
    Why
    Exclude malignant hypertension, anaemia and history-led systemic or medicine-associated intracranial hypertension.
    Interpretation and limitations
    Severe blood pressure elevation changes the emergency pathway; anaemia or a causal exposure must be treated and the disorder should not remain labelled idiopathic.

Differential diagnosis

01

Cerebral venous sinus thrombosis

Headache and papilloedema are indistinguishable clinically; normal CT or MR venography is required before raised pressure is labelled idiopathic.

02

Mass lesion or hydrocephalus

Tumour, abscess and obstructed cerebrospinal-fluid pathways produce raised pressure with structural imaging abnormalities and may make lumbar puncture hazardous.

03

Pseudopapilloedema

Optic-disc drusen or congenitally crowded discs can look swollen without true pressure-related leakage; competent ophthalmic imaging and visual assessment distinguish them.

04

Migraine with incidental disc appearance

Migraine commonly causes headache, but does not explain confirmed papilloedema, sixth-nerve palsy or pressure-related visual-field loss.

Management

01Suspected papilloedemaProtect sight while confirming pressureFirst stepDisc swelling or pressure-related visual symptoms are identified.+
  1. 1Measure blood pressure, acuity, pupils and fields urgently, obtain experienced confirmation of papilloedema and identify rapidly changing vision.
  2. 2Arrange urgent brain imaging with venography to exclude mass, hydrocephalus and cerebral venous sinus thrombosis before lumbar puncture.
  3. 3When safe, perform a technically correct lateral-decubitus lumbar puncture with opening pressure and normal-composition studies.
  4. 4Coordinate neurology and ophthalmology so diagnosis, visual-risk grade and ownership of follow-up are explicit from the outset.
02Stable visionModify disease and monitor functionIIH is confirmed without rapidly deteriorating visual function.+
  1. 1

Complications

01

Permanent visual loss

Sustained papilloedema causes optic-nerve atrophy and irreversible field or acuity loss, sometimes despite relatively modest headache.

02

Diplopia and functional restriction

Sixth-nerve palsy and transient visual obscurations interfere with reading, driving, work and safe mobility during active disease.

03

Chronic headache disability

Headache may persist after pressure control through coexisting migraine or sensitisation, driving repeated procedures and medication overuse if phenotypes are not separated.

04

Treatment-related morbidity

Serial punctures, medicines and shunts can cause low-pressure headache, electrolyte or kidney effects, infection, obstruction and revision burden.

Monitoring and follow-up

  • Repeat formal visual fields, acuity, pupils and optic-disc grading or OCT at a frequency based on baseline papilloedema, field loss and recent trajectory.
  • Ask about transient obscurations, sustained visual change and diplopia at every contact, arranging same-day reassessment for deterioration rather than awaiting a routine appointment.
  • During acetazolamide treatment monitor renal function, electrolytes or bicarbonate according to dose, symptoms, comorbidity and local specialist protocol.
  • Track weight and access to supported intervention without making continued care conditional on weight loss or using stigmatising language.
  • Keep headache days and acute medicine exposure separate from visual outcomes, because papilloedema can improve while chronic migraine morbidity persists.
  • After surgery monitor shunt or wound complications, recurrent papilloedema and visual function, and continue long-term disease-modifying support.

Special situations

Vision outranks pain

Headache severity correlates poorly with optic-nerve threat. Formal fields and disc trajectory, not pain score, determine sight-saving urgency.

Venography is not optional

Cerebral venous sinus thrombosis can produce the same raised-pressure syndrome and must be excluded before the label idiopathic is justified.

Pressure is a measured context

Leg flexion, straining, anxiety and technique influence lumbar-puncture readings; a solitary borderline number should not outweigh the rest of the diagnostic picture.

Empty sella is supportive

Imaging features associated with raised pressure can strengthen a coherent diagnosis but occur incidentally and cannot replace papilloedema, CSF and exclusion criteria.

Headache may outlive papilloedema

Persistent pain after pressure control is often migraine-like and needs standard headache prevention rather than repeated invasive pressure procedures.

Weight care needs respect

Weight reduction is genuinely disease modifying in obesity-associated IIH, but access, biology and stigma must be addressed through supported shared care rather than blame.

Common pitfalls

  1. 01

    Diagnosing IIH from obesity and headache alone without confirming papilloedema, excluding venous thrombosis and measuring CSF pressure correctly.

  2. 02

    Performing lumbar puncture before appropriate imaging and safety assessment in a patient with possible raised intracranial pressure or mass effect.

  3. 03

    Treating a borderline opening pressure as definitive while ignoring patient position, straining, sedation and a clinically discordant picture.

  4. 04

    Monitoring central visual acuity alone and missing progressive peripheral field loss from papilloedema.

  5. 05

    Using serial lumbar punctures as routine long-term therapy despite short-lived benefit and failure to protect rapidly deteriorating vision definitively.

  6. 06

    Escalating acetazolamide solely for headache after papilloedema resolves rather than classifying and treating the residual migraine phenotype.

  7. 07

    Using topiramate without applying current pregnancy-prevention restrictions or recognising cognitive and ocular adverse effects.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
NeurologyOriginal SBA

Completing the diagnostic sequence

A patient has confirmed bilateral papilloedema and pulsatile tinnitus. MRI brain and MR venography show no mass or venous thrombosis. What investigation most directly completes the diagnostic assessment when the procedure is safe?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Neurology topics →
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UK consensus guidelines on IIH managementMultispecialty diagnostic, visual-monitoring, weight, medicine and surgical pathway.
  • Practical Neurology IIH diagnosis and management updateUK clinical application of pressure measurement, imaging and follow-up.
  • BNF acetazolamide monographContraindications, adverse effects, interactions and prescribing safety.
  • MHRA topiramate pregnancy prevention measuresCurrent reproductive safety restrictions relevant to migraine-pattern headache treatment.
  • NICE CG150 headache diagnosis guidanceHeadache assessment, diary use and secondary-feature principles.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom

Management has three aims: preserve sight, modify disease and treat headache morbidity. Urgently declining fields or acuity requires surgical discussion; UK practice commonly uses cerebrospinal-fluid diversion or optic-nerve-sheath fenestration according to local expertise and the pattern of visual threat. Temporising lumbar drainage may bridge to definitive care, but serial lumbar punctures are not routine therapy. For patients with obesity, supported weight loss is disease modifying and bariatric pathways may be appropriate. Acetazolamide reduces CSF production and can improve visual outcomes in mild visual loss, titrated against paraesthesia, fatigue, gastrointestinal disturbance, renal stones and metabolic acidosis. Topiramate may help migraine phenotype, appetite and carbonic-anhydrase activity, but cognitive effects and strict MHRA pregnancy-prevention restrictions constrain use. Treat headache according to phenotype, prevent medication overuse and do not use acetazolamide escalation as a substitute for migraine care.

Key points

  • Idiopathic intracranial hypertension is raised intracranial pressure with normal cerebrospinal-fluid composition and no mass, hydrocephalus, venous thrombosis or other secondary cause on appropriate investigation.
  • Headache is common but non-specific; papilloedema, transient visual obscurations, pulsatile tinnitus and sixth-nerve palsy provide more diagnostic and risk information.
  • Confirm suspected papilloedema with competent ophthalmic assessment, documenting visual acuity, pupils, formal visual fields and optic-disc appearance or imaging.
  • Urgent MRI or CT must exclude structural disease, and CT or MR venography is required to exclude cerebral venous sinus thrombosis before the condition is called idiopathic.
  • After safe normal imaging, perform lumbar puncture in the lateral decubitus position with a relaxed patient, measure opening pressure correctly and analyse normal CSF constituents.
  • An adult opening pressure above 25 cm CSF supports diagnosis, but a single measurement must be interpreted with the complete phenotype, technique and imaging.
  • Weight loss is the only established disease-modifying therapy in patients with obesity; frame support respectfully and offer access to structured weight-management services.
  • Acetazolamide can be used to protect visual function in selected patients, but it is not established as a treatment for headache alone and adverse effects often limit dosing.
  • Serial therapeutic lumbar punctures are not recommended for routine management because benefit is short-lived; deteriorating vision needs definitive specialist escalation.
  • 05
    BMI and metabolic assessment
    Why
    Plan respectful disease-modifying weight support and identify comorbidity relevant to medicines or surgery.
    Interpretation and limitations
    Weight is a treatment domain rather than a diagnostic shortcut; IIH still requires complete pressure, imaging, CSF and visual assessment.
  • 06
    Headache and medicine diary
    Why
    Classify coexisting migraine phenotype, quantify disability and detect medication overuse separately from visual disease.
    Interpretation and limitations
    Headache may persist after pressure and papilloedema improve; manage the residual phenotype directly instead of repeatedly draining CSF.
    • Explain the diagnosis and visual risk, review secondary associations and provide a respectful supported weight-management referral where obesity is present.
  • 2Consider acetazolamide for visual protection, titrating through specialist or local protocol while monitoring tolerability, renal risk and acid-base effects.
  • 3Treat migraine-like headache with an appropriate acute and preventive plan, limiting rescue days and avoiding routine repeated lumbar puncture.
  • 4Schedule perimetry and optic-disc review at an interval determined by papilloedema grade, field loss and trajectory, shortening it for any concern.
    • 03Vision decliningEscalate to definitive sight-saving careDefinitiveEscalationVisual fields or acuity worsen despite medical and disease-modifying management.+
    1. 1Arrange immediate joint neuro-ophthalmology and neurosurgical review, repeating reliable fields and excluding a new secondary mechanism without delaying protection.
    2. 2DefinitiveUse short-term lumbar drainage only as a specialist bridge when necessary, not as a recurring outpatient substitute for definitive care.
    3. 3Select CSF diversion or optic-nerve-sheath fenestration according to visual pattern, local expertise, patient factors and multidisciplinary judgement.
    4. 4Continue postoperative visual surveillance and disease modification because shunt complications, recurrence and persistent migraine-like headache require separate management.
    Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
    Reduces cerebrospinal-fluid production and can support visual protection in confirmed IIH with papilloedema or mild visual loss.

    Acetazolamide

    A common specialist start is 250–500 mg twice daily, titrated according to visual response, adverse effects, renal function and the local IIH protocol.

    Paraesthesia, fatigue, gastrointestinal symptoms, taste change, renal stones and metabolic acidosis are common concerns; review renal disease, electrolytes, sulfonamide reactions and pregnancy.

    May help a coexisting migraine phenotype, suppress appetite and provide weak carbonic-anhydrase inhibition in a selected patient.

    Topiramate

    If selected by a specialist, begin at a low nightly dose and titrate slowly using migraine guidance and the lowest effective tolerated regimen.

    Cognitive and mood effects, stones and acute angle closure matter; it is contraindicated for migraine prevention in pregnancy and MHRA Pregnancy Prevention Programme conditions apply.